Potential role of intratumor bacteria in mediating tumor resistance to the chemotherapeutic drug gemcitabine.
about
Whole Genome Sequencing Analysis for Cancer Genomics and Precision Medicine.Recovery of Immunoglobulin VJ Recombinations from Pancreatic Cancer Exome Files Strongly Correlates with Reduced Survival.Microbiome facilitated pest resistance: potential problems and uses.Gut microbiome influences on anastomotic leak and recurrence rates following colorectal cancer surgery.Integrative analysis of exogenous, endogenous, tumour and immune factors for precision medicine.Pancreatic cancer: Intra-tumour bacteria promote gemcitabine resistance in pancreatic adenocarcinoma.Cancer treatment: Bacterial snack attack deactivates a drug.Intratumoral bacteria may elicit chemoresistance by metabolizing anticancer agents.The Complex Interplay between Chronic Inflammation, the Microbiome, and Cancer: Understanding Disease Progression and What We Can Do to Prevent It.Diets That Promote Colon Inflammation Associate With Risk of Colorectal Carcinomas That Contain Fusobacterium nucleatum.No effects without causes: the Iron Dysregulation and Dormant Microbes hypothesis for chronic, inflammatory diseases.Concepts Collide: Genomic, Immune, and Microbial Influences on the Tumor Microenvironment and Response to Cancer Therapy.Pharmacomicrobiomics: exploiting the drug-microbiota interactions in anticancer therapies.Microbial markers in colorectal cancer detection and/or prognosis.Pancreatic Cancer: Molecular Characterization, Clonal Evolution and Cancer Stem Cells.PD-L1 is expressed on human platelets and is affected by immune checkpoint therapy.Sputum Detection of Predisposing Genetic Mutations in Women with Pulmonary Nontuberculous Mycobacterial DiseaseMolecular mechanisms of the preventable causes of cancer in the United StatesGrow With the Challenge - Microbial Effects on Epithelial Proliferation, Carcinogenesis, and Cancer TherapyPrediction Methods of Herbal Compounds in Chinese Medicinal HerbsMolecular Diagnostics in Clinical OncologyAlterations of fecal bacterial communities in patients with lung cancer
P2860
Q47725702-247F89F7-A957-417E-820F-E2D78396197DQ48100699-0DF091C0-46AC-4CB6-AEE5-B6329F758C30Q48124051-589A9E6D-3064-4C41-BCB1-F53556CC2273Q48229412-374A53DF-B3C2-4228-BE2B-BF92B28334A5Q50043586-E67D2865-E9FE-4CC8-B5B9-77012D0D6A7CQ50091500-CBD561ED-AC11-4779-8583-5C239533B250Q50100893-E92036FE-7498-4AD2-9E15-5A5E6CF334CBQ50195439-57121D57-2247-4B94-86DA-146080ACB58CQ52349005-BF757CFE-F18D-467B-85AF-75DECD762ACFQ52558651-E577752A-24CE-4CD5-AF2E-C38FDB5451F9Q53698735-F457989A-B8DB-40E3-9432-0226254ECBB9Q55034685-C41BC447-92D4-4525-A6BF-BF80689303DCQ55040688-0D4C4589-1CA5-4A57-A25F-F8AC4B241185Q55094334-6DEE179D-3FDE-4A5C-8DE5-6A65CAC84F51Q55104265-38BC93E2-A98C-4EE3-A7B8-5DAAD0A9C873Q55262520-411F9F1F-B9FA-40B7-9E71-06BBC30BD98FQ56395598-EF6C1B48-9F92-4A4A-A048-44158FDDB81BQ56475873-992544FE-D318-4269-A086-A62A4F98A00DQ57191774-6992785A-F18D-4454-8A4D-50A4893BBDFBQ58696501-0CEA831A-B60C-4884-B1A0-45759FBB3E5FQ58700723-3B30F8B2-81E0-4CFC-898B-B6648BA82474Q58733994-CD5EDA01-0132-4DA7-9E66-30B6F03F6099
P2860
Potential role of intratumor bacteria in mediating tumor resistance to the chemotherapeutic drug gemcitabine.
description
2017 nî lūn-bûn
@nan
2017年の論文
@ja
2017年論文
@yue
2017年論文
@zh-hant
2017年論文
@zh-hk
2017年論文
@zh-mo
2017年論文
@zh-tw
2017年论文
@wuu
2017年论文
@zh
2017年论文
@zh-cn
name
Potential role of intratumor b ...... otherapeutic drug gemcitabine.
@en
type
label
Potential role of intratumor b ...... otherapeutic drug gemcitabine.
@en
prefLabel
Potential role of intratumor b ...... otherapeutic drug gemcitabine.
@en
P2093
P2860
P50
P356
P1433
P1476
Potential role of intratumor b ...... otherapeutic drug gemcitabine.
@en
P2093
Alexander Brandis
Carrie M Mosher
Christoph A Thaiss
Cristina R Ferrone
Dennie T Frederick
Garold Fuks
Iris Barshack
Keith T Flaherty
Matt Skalak
Matthew Katz
P2860
P304
P356
10.1126/SCIENCE.AAH5043
P407
P50
P577
2017-09-01T00:00:00Z